Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
Balance Foot & Ankle offers same-day appointments for urgent foot and ankle conditions across Southeast Michigan — but the most important factor in outcomes isn’t getting seen quickly. Our podiatrists explain what to do in the first 24-48 hours before your appointment that most patients skip entirely. Call (810) 206-1402 — expert podiatric care across Michigan.
| Feature | Giant Cell Tumor of Tendon Sheath (GCTTS) | Ganglion Cyst | Lipoma | Plantar Fibroma |
|---|---|---|---|---|
| Origin | Synovial sheath of tendon; locally aggressive benign tumor | Mucinous degeneration from joint capsule or tendon sheath | Adipose tissue | Plantar aponeurosis; fibroblastic proliferation |
| Common Location (foot/ankle) | Flexor tendon sheaths; plantar foot; dorsal foot; ankle | Dorsal wrist; foot dorsum; ankle; tarsals | Plantar foot; heel; dorsum | Plantar fascia mid-arch; medial band |
| Appearance on Exam | Firm, lobulated, non-transilluminating; attached to tendon sheath; may cause joint erosion | Soft, fluctuant; transilluminates; may disappear with pressure | Soft, mobile, rubbery; non-tender; not attached to tendon | Firm, fixed nodule in plantar fascia; tender with WB |
| MRI Signal | T1 low; T2 low (hemosiderin causes dark signal); heterogeneous; enhances with contrast | T1 low; T2 bright (fluid); thin wall; no internal architecture | T1 bright (fat); suppresses on STIR; homogeneous | T1 intermediate; T2 variable; within plantar fascia |
| Recurrence After Excision | 10–44% (locally infiltrative; must excise all satellite nodules) | ~15–20% (incomplete excision of stalk); lower with arthroscopic | <5% | ~10–20% (especially Ledderhose disease) |
| Treatment | Indication | Details | Recurrence Risk | Recovery |
|---|---|---|---|---|
| Surgical Excision (marginal resection) | All symptomatic GCTTS; standard of care | Complete en-bloc excision with all satellite nodules; meticulous tendon sheath clearance | 10–44% — correlate with incomplete excision and diffuse-type histology | 2–4 weeks partial WB; PT for ROM; 6–8 weeks full activity |
| Observation | Asymptomatic incidental finding; confirmed benign on MRI | Serial MRI every 6–12 months; excise if growing or symptomatic | N/A — monitoring | None |
| Post-Excision Radiotherapy | Diffuse-type GCTTS with high recurrence risk; multiply recurrent | Low-dose adjuvant RT after excision for diffuse type | Reduces recurrence in high-risk cases; routine in early excision not warranted | Standard RT scheduling |
| Biologic Therapy (pexidartinib) | Locally advanced or unresectable diffuse-type GCTTS (TGFSS) | CSF1R inhibitor; FDA approved 2019 for unresectable GCTTS | Targets tumor biology; not curative but controls growth | Oral; hepatotoxicity monitoring required |
Watch: Heel Bursitis & Achilles Tendon Bursitis [Best HOME Treatment!] — MichiganFootDoctors YouTube
Foot pain isn't resolving?
Same-week appointments at Howell & Bloomfield Hills
Medically Reviewed | Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle, Michigan
Giant cell tumor of the tendon sheath (GCTTS)—also known as pigmented villonodular tenosynovitis (PVNS) in its diffuse form—is the most common benign soft tissue tumor of the hand, and one of the most common benign masses encountered in the foot and ankle. Despite its intimidating name, GCTTS is not cancerous and does not spread to other organs. However, it can cause significant local problems and has a meaningful recurrence rate after incomplete surgical excision.
What Is Giant Cell Tumor of the Tendon Sheath?
Giant cell tumor of the tendon sheath is a benign neoplasm that arises from the synovial lining of tendon sheaths. In the foot, the most commonly affected locations are the tendon sheaths around the flexor and extensor tendons of the toes, the peroneal tendons, and the posterior tibial tendon sheath. The tumor derives its name from the large, multinucleated giant cells that are characteristic on histopathological examination—interspersed with mononuclear stromal cells, foam cells (lipid-laden histiocytes), and hemosiderin deposits (the source of the “pigmented” descriptor in PVNS).
Two forms are recognized: the localized (nodular) form—the classic GCTTS, presenting as a discrete, well-encapsulated nodule arising from a tendon sheath—and the diffuse form (diffuse PVNS), which involves the entire synovial lining of a joint or tendon sheath compartment and is significantly more aggressive in its local behavior and recurrence potential. The localized form is far more common in the foot and ankle.
How Does GCTTS Present Clinically?
The typical presentation is a slow-growing, firm, well-defined mass adjacent to a tendon on the foot or ankle. The mass is usually non-tender or only mildly uncomfortable on direct pressure, and it may have been present for months to years before the patient seeks evaluation. Skin color overlying the mass is normal—distinguishing it from inflammatory conditions with skin changes. The mass is fixed to the underlying tendon sheath but moves with the tendon—asking the patient to flex and extend the adjacent toe while palpating the mass often demonstrates this movement characteristic.
The mass rarely causes neurological symptoms unless it compresses an adjacent nerve—in which case paresthesias or numbness in the distribution of the compressed nerve may occur. In the foot, proximity to the digital nerves can cause toe numbness. Proximity to the tarsal tunnel may mimic tarsal tunnel syndrome.
Diagnosis: Imaging and Biopsy
MRI is the imaging modality of choice for GCTTS. The hemosiderin content of the tumor creates characteristic low signal on both T1 and T2 weighted sequences—distinguishing GCTTS from most other soft tissue masses that appear bright on T2. This “blooming” low-signal appearance on gradient echo sequences is highly characteristic and often allows confident pre-operative diagnosis. MRI also delineates tumor size, relationship to adjacent tendons and neurovascular structures, and extent of involvement—all critical for surgical planning.
While MRI findings are often sufficient for clinical planning, definitive diagnosis requires histopathological confirmation from the excised specimen. Pre-operative biopsy is rarely needed for classic presentations, as the surgical plan—complete excision—is the same regardless of biopsy findings. Atypical presentations or large masses with aggressive features on MRI may warrant pre-operative biopsy to rule out malignant soft tissue tumors (sarcomas), which require fundamentally different oncologic management.
Surgical Treatment: Complete Excision
The treatment for GCTTS is complete surgical excision. The goal is to remove the entire tumor including its pseudocapsule, leaving no residual tumor tissue behind—because even microscopic residual disease can lead to regrowth. This requires careful dissection under tourniquet control, with excellent visualization of the tumor’s relationship to the adjacent tendon. The tendon sheath is excised along with the tumor wherever involved, and the surgeon systematically inspects the wound for satellite nodules—small separate tumor deposits that must also be excised.
Recurrence rates for localized GCTTS following complete excision are 10–20%—higher than for most benign tumors, but manageable with careful follow-up and prompt re-excision if recurrence is detected. Recurrence is significantly higher (40–50% or more) for the diffuse PVNS form and when initial resection was incomplete. For this reason, cases should be performed by a surgeon with experience in foot and ankle soft tissue tumor management who understands why we complete removal.
Recovery following GCTTS excision depends on the tumor’s location and size. Small masses in the toe region may allow immediate protected weight-bearing with a surgical shoe. Larger masses near major tendons require a brief period of restricted activity to allow tendon sheath healing. Physical therapy is infrequently needed but may be recommended when excision involved significant tendon sheath dissection.
If you have noticed a slowly growing mass on your foot, ankle, or toe, Dr. Biernacki provides expert evaluation to characterize the mass—distinguishing GCTTS from other benign masses (ganglion cysts, lipomas, neuromas) and from the rare malignant soft tissue tumors that require oncologic care. Don’t delay evaluation of a growing foot mass—early accurate diagnosis ensures the right treatment.
Dr. Tom's Product Recommendations
Mueller Adjust-to-Fit Toe Brace
⭐ Highly Rated | Foundation Wellness Partner | 30% Commission
Protective toe brace for post-excision recovery when GCTTS was adjacent to digital tendons—reduces motion and friction during healing.
Dr. Tom says: “Kept my toe protected after surgery while I wore regular shoes to work.”
Post-operative GCTTS excision with toe tendon sheath involvement
Pre-operative patients (surgical evaluation and excision needed first)
Disclosure: We earn a commission at no extra cost to you.
New Balance 990v5 Walking Shoes Wide Width
⭐ Highly Rated | Foundation Wellness Partner | 30% Commission
Wide-toe-box shoes that accommodate post-surgical swelling and reduce pressure on foot mass or post-excision site.
Dr. Tom says: “These gave my foot room while the surgical area healed—much more comfortable than my regular shoes.”
Post-excision patients needing wide, accommodative footwear during recovery
Patients whose mass is in a location requiring specialized surgical footwear (follow surgeon guidance)
Disclosure: We earn a commission at no extra cost to you.
TheraBand Foot Roller for Soft Tissue Mobility
⭐ Highly Rated | Foundation Wellness Partner | 30% Commission
Foot roller for post-surgical soft tissue mobility—helps maintain tendon gliding function during GCTTS recovery phase.
Dr. Tom says: “Helped me regain flexibility in the tendon area after the surgery healed.”
Cleared-for-mobility patients in post-GCTTS excision rehabilitation phase
Early post-operative patients (clearance from Dr. Biernacki required before use)
Disclosure: We earn a commission at no extra cost to you.
✅ Pros / Benefits
- GCTTS is benign—complete excision is curative with no metastatic risk
- MRI provides characteristic low-signal appearance that often confirms diagnosis pre-operatively
- Localized form has good outcomes with complete surgical excision and careful follow-up
❌ Cons / Risks
- Recurrence rate of 10–20% for localized GCTTS requires post-operative surveillance
- Diffuse PVNS form has 40–50%+ recurrence and is significantly more challenging to manage
- Incomplete excision substantially increases recurrence risk—requires experienced surgical technique
Dr. Tom Biernacki’s Recommendation
When a patient comes to me with a slowly growing mass on their foot or ankle, my first priority is making sure we understand exactly what it is. Most of the time these masses turn out to be benign—ganglion cysts, lipomas, or giant cell tumors of the tendon sheath—and the treatment is straightforward. For GCTTS, the key message I give patients is that complete removal matters more than the size of the incision. I’d rather have a slightly larger but clean excision than a minimal approach that leaves tumor behind and requires a second surgery. If you’ve noticed a firm, slow-growing lump on your foot or ankle that’s been there for months and isn’t going away, it’s worth having it evaluated. Most are benign, but knowing for certain—and treating definitively—is always the right call.
— Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle
Frequently Asked Questions
Is giant cell tumor of the tendon sheath cancerous?
No—GCTTS is a benign (non-cancerous) tumor. It does not spread to other organs or become malignant. However, it can cause local problems including pressure on adjacent tendons, nerves, and blood vessels, and it can recur after incomplete surgical excision. Complete removal is the goal of treatment.
How fast does GCTTS grow?
GCTTS typically grows slowly—often over months to years before patients seek evaluation. Rapid growth or sudden change in a previously stable mass should prompt urgent evaluation to rule out malignant soft tissue tumors, which are rare but require very different management.
What does GCTTS feel like on the foot?
GCTTS typically feels like a firm, rubbery, well-defined nodule beneath the skin, fixed to an underlying tendon. It is usually non-tender or only mildly uncomfortable on direct pressure. The overlying skin appears normal. The mass may move slightly when the adjacent toe or foot is flexed and extended.
What is the recurrence rate after GCTTS surgery?
Localized GCTTS has a 10–20% recurrence rate following complete surgical excision. Diffuse PVNS has substantially higher recurrence rates of 40% or more. Regular post-operative follow-up allows early detection of recurrence, which is treated with re-excision.
How do I schedule an evaluation for a foot mass at Balance Foot & Ankle?
Schedule online 24/7 at MichiganFootDoctors.com or call (517) 579-1881. For masses that have been growing, changing rapidly, or causing pain, early evaluation is recommended. Dr. Biernacki will perform clinical examination, order appropriate imaging, and develop a clear diagnosis and treatment plan.
Michigan Foot Pain? See Dr. Biernacki In Person
4.9★ rated | 1,123 Reviews | 3,000+ Surgeries
Same-week appointments · Howell & Bloomfield Hills
📞 (810) 206-1402 Book Online →Frequently Asked Questions
When should I see a podiatrist?
If symptoms persist past 2 weeks, affect your normal activity, or are accompanied by red-flag symptoms (warmth, redness, swelling, inability to bear weight).
What does treatment cost?
Most diagnostic visits and conservative treatments are covered by Medicare and major insurers. Out-of-pocket costs vary by your specific plan.
How quickly can I get an appointment?
Most non-urgent cases see us within 5 business days. Urgent cases (sudden pain, possible fracture) typically same or next business day.
Visit Balance Foot & Ankle — Same-Day Appointments Available
Our podiatry team serves patients throughout Michigan including Howell, Brighton, and Bloomfield Hills. If you’re dealing with heel pain, ingrown toenails, or a foot injury, we have same-day appointment availability.
American Podiatric Medical Association: Find a Podiatrist
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.